BD 2142010 - PowerLoc MAX PAK Safety Infusion Set, 20G x 1", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2142010 - PowerLoc MAX PAK Safety Infusion Set, 20G x 1", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2142010 PowerLoc MAX PAK Safety Infusion Set is a sterile, single-use port-access device designed for accessing compatible subcutaneously implanted vascular ports. The set features a 20-gauge non-coring needle with a 1-inch length and is configured without a Y-injection site.

The PowerLoc MAX system provides a fluid pathway for administering compatible medications and solutions, withdrawing blood specimens, flushing implanted ports, and delivering contrast media through appropriately rated power-injectable ports. The 20-gauge configuration supports routine infusion therapy and compatible diagnostic imaging procedures, while the 1-inch needle length accommodates ports positioned at a moderate depth beneath the skin.

An integrated safety mechanism is housed within the needle base. During port deaccessing, the needle is withdrawn through the base, allowing the safety mechanism to cover the needle bevel and lock it within the protective housing. This single-step activation is designed to help reduce accidental needlestick exposure during removal, transportation, and disposal.

The low-profile, wingless base supports dressing application and ongoing access-site care. Its padded, non-absorbent footprint is designed to support patient comfort, while the rotating needle hub allows clinicians to position the tubing according to the dressing configuration and treatment environment.

The MAX PAK presentation provides an organized solution intended to simplify the multi-step sterile port-access preparation process. BD 2142010 is supplied five sets per case.

Key Benefits

• 20-gauge non-coring needle supports access to compatible implanted vascular ports.
• One-inch needle length accommodates appropriately positioned ports with moderate tissue depth.
• Power-injectable configuration supports compatible contrast-enhanced imaging procedures.
• Supports power-injection flow rates up to 5 mL per second when all connected components are compatible and properly rated.
• Integrated safety mechanism covers and locks the needle bevel following removal.
• Single-step safety activation helps reduce accidental needlestick exposure.
• Low-profile base supports secure dressing placement and routine access-site management.
• Wingless design helps reduce bulk beneath the dressing.
• Non-absorbent padded footprint is designed to promote patient comfort.
• Rotating needle hub supports convenient tubing positioning and maneuverability.
• Stable needle base helps maintain access-device positioning during therapy.
• Compatible with appropriate dual-lumen implanted vascular ports.
• Configuration without a Y-injection site provides a direct fluid pathway.
• MAX PAK format helps organize components used during sterile port-access preparation.
• Five-per-case packaging supports controlled inventory management.

Compatibility and Applications

The BD 2142010 PowerLoc MAX PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, port flushing, and contrast-media delivery during compatible diagnostic imaging procedures.

When used for power injection, the implanted port, access needle, tubing, connectors, extension components, and every other device within the fluid pathway must be specifically identified as power injectable. The operating pressure and flow rate must not exceed the lowest-rated component within the complete system.

The 20-gauge needle offers a balance between flow performance and needle diameter. It may be selected for routine infusion, blood withdrawal, and compatible power-injection applications when a 20-gauge device meets the requirements of the prescribed procedure and implanted port.

The 1-inch length may be appropriate when the port septum is positioned too deeply for a 0.75-inch needle but does not require a longer 1.5-inch configuration. Needle length must be selected according to the patient's tissue depth and implanted port position.

The set does not include a Y-injection site. It is suitable for workflows that use a direct connection and do not require a secondary medication or injection-access point within the tubing.

Compatibility should be confirmed with the exact implanted port model, septum design, port depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access protocol.

Usage Guidelines

The BD 2142010 should be used only by healthcare professionals who are trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status.
• Assess the position and depth of the implanted port before selecting the 1-inch needle.
• Verify that the 20-gauge configuration is appropriate for the intended infusion, blood withdrawal, or imaging procedure.
• Inspect the sterile package for moisture, punctures, damage, contamination, or compromised integrity.
• Prepare the port-access site using the antiseptic procedure required by institutional policy.
• Prime the tubing completely with an approved solution using aseptic technique.
• Remove all air from the fluid pathway before connecting the set to the implanted port.
• Stabilize the port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement according to institutional policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Position the rotating hub and tubing to reduce pressure, pulling, twisting, and dressing disruption.
• Secure the set and apply an approved sterile dressing.
• Monitor the access site for pain, swelling, redness, leakage, displacement, or other complications.
• Confirm power-injection eligibility before connecting the set to a power injector.
• Do not exceed the permitted pressure or flow limit of any connected component.
• After therapy, flush and lock the port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the safety mechanism.
• Confirm that the needle bevel is fully covered and locked within the protective base.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, or other abnormalities develop at the access site.

Certifications and Safety Standards

The BD 2142010 PowerLoc MAX PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The product is supplied sterile and intended for single use. Maintaining package integrity and following appropriate aseptic technique are essential for preserving the sterile condition before use.

The integrated safety mechanism supports occupational exposure-control procedures by covering and locking the needle bevel after removal. This feature does not replace proper sharps handling, personal protective equipment, clinician training, or immediate disposal in an approved sharps container.

The PowerLoc MAX platform includes a non-coring needle intended to minimize damage to the septum of a compatible implanted port. The device should be incorporated into facility procedures covering port assessment, sterile access, securement, dressing management, infusion administration, power injection, deaccessing, and sharps disposal.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, maximum pressure, flow-rate limits, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional port-access needles without safety features, the BD PowerLoc MAX includes an integrated mechanism that covers and locks the needle bevel during deaccessing. This can help reduce accidental needlestick exposure between removal and final disposal.

Compared with winged Huber needle sets, the wingless and low-profile base may simplify dressing placement and improve access-site visibility. Winged designs may still be preferred when clinicians require wings for insertion control or stabilization.

Compared with non-power-injectable port-access sets, the PowerLoc MAX supports power injection when used with a compatible power-injectable port and within the specified operating limits. Non-power-rated needles should not be used for procedures requiring powered contrast-media delivery.

Compared with sets containing a Y-injection site, BD 2142010 provides a direct tubing pathway without a secondary access point. This may reduce unnecessary connections when secondary medication administration is not required.

Compared with the 0.75-inch model, the 1-inch needle accommodates ports positioned at a greater depth beneath the skin. Compared with a 1.5-inch configuration, it may provide a lower profile when the additional needle length is unnecessary.

Compared with 19-gauge configurations, the 20-gauge needle has a smaller external diameter while retaining suitable flow capability for many infusion and power-injection procedures. Compared with 22-gauge options, the 20-gauge configuration supports a higher manufacturer-specified power-injection rate.

Alternative safety infusion sets may vary in gauge, needle length, power-injection rating, safety activation method, base design, padding, tubing configuration, Y-site availability, included preparation components, and package quantity. BD 2142010 combines a 20-gauge, 1-inch non-coring needle with a low-profile base, integrated safety feature, and MAX PAK presentation.

Typical User Profile and Application Scenarios

The BD 2142010 PowerLoc MAX PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted ports are routinely accessed.

The product may be selected for patients whose implanted port requires a 1-inch access needle and whose prescribed treatment or diagnostic procedure is compatible with a 20-gauge device.

Typical application scenarios include chemotherapy, antibiotic infusion, hydration therapy, parenteral nutrition, blood specimen collection, routine port maintenance, and power injection of contrast media during compatible imaging procedures.

The configuration without a Y-injection site is particularly relevant when a direct connection is preferred and the treatment plan does not require secondary access through the infusion tubing.

Best Practices for Use and Maintenance

The BD 2142010 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on proper storage, product selection, sterile preparation, access technique, site monitoring, safety activation, and disposal.

• Store unopened sets under the environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2142010 catalog number before opening the package.
• Confirm the 20-gauge size, 1-inch length, and absence of a Y-injection site.
• Assess the patient's port depth before selecting the needle length.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the tubing completely before connecting it to the implanted port.
• Stabilize the port during both insertion and removal.
• Use the rotating hub to position the tubing without creating tension at the access site.
• Monitor the access site throughout therapy for infiltration, extravasation, infection, leakage, or displacement.
• Verify the power-injectable status of the complete access system before a powered procedure.
• Never exceed the lowest pressure or flow-rate limit of any connected component.
• Do not bend, cut, modify, repair, or otherwise alter the device.
• Do not reuse, clean, resterilize, or reprocess the single-use set.
• Verify complete safety activation immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2142010 PowerLoc MAX PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 20-gauge size, 1-inch needle length, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every connected component are specifically rated for power injection. The permitted pressure, flow rate, contrast-media viscosity, and other operating conditions must be verified before beginning the procedure.

Compatible 20-gauge PowerLoc MAX configurations support power-injection flow rates up to 5 mL per second when used under the conditions specified by the manufacturer. The lowest-rated component within the entire system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may cause infiltration, extravasation, tissue injury, leakage, port damage, interrupted treatment, or other complications.

Because this model does not include a Y-injection site, it does not provide a secondary medication-access point within the tubing. Clinical teams should confirm that the direct configuration is suitable for the intended procedure before opening the package.

The integrated safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp even after the needle bevel is covered and must be discarded immediately in an approved sharps container.

The product is supplied five sets per case. Distributor listings may identify it as temperature sensitive, non-returnable, restricted to continental United States distribution, or subject to special-order requirements. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, and return conditions before ordering.

How to Order

Select the BD 2142010 - PowerLoc MAX PAK Safety Infusion Set without Y-Injection Site, 20G x 1" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.